EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Growth hormone secretagogue receptor and cannabinoid receptor type 1 intersection in the mouse brain

Camila Saenz, Gimena Fernandez, Ramiro Llovera, María J Tolosa, Sonia Cantel, Jean-Alain Fehrentz, Kenneth Mackie, Lorenzo Leggio, Jeffrey Zigman, Pablo N De Francesco, Mario Perello

Brain Structure and Function · 2024

DOI: 10.1007/s00429-024-02876-3 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Brain Structure and Function, 2024. Verfasst von Camila Saenz und 10 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Neurophysiology of the Multidisciplinary Institute of Cell Biology [IMBICE, Argentine Research Council (CONICET) and Scientific Researc…. Hauptthemen laut MEDLINE: Receptors, Ghrelin, Brain, Receptor, Cannabinoid, CB1, Neurons. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 110 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIDDK NIH HHS, Fondo para la Investigación Científica y Tecnológica, Ministerio de Ciencia, Tecnología e Innovación.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The growth hormone secretagogue receptor (GHSR) and the cannabinoid receptor type 1 (CB1R) are G-protein coupled receptors highly expressed in the brain and involved in critical regulatory processes, such as energy homeostasis, appetite control, reward, and stress responses. GHSR mediates the effects of both ghrelin and liver-expressed antimicrobial peptide 2, while CB1R is targeted by cannabinoids. Strikingly, both receptors mediate their effects by acting on common brain areas and their individual roles have been well characterized. However, the potential for their co-expression in the same neuronal subsets remains largely unexplored. Here, we aim to map the cell populations where GHSR and CB1R might converge, hypothesizing that their co-expression in specific brain circuits could mediate integrated physiological responses. By utilizing two complementary labeling techniques—GHSR-eGFP mice and Fr-ghrelin labeling of GHSR+ cells—along with specific CB1R immunostaining, we sought to visualize and quantify potential areas of overlap. Also, we analyzed several cell RNA sequencing datasets to estimate the fraction of brain cells expressing both GPCRs and their phenotype. Our neuroanatomical studies revealed evident overlap of GHSR+ and CB1R+ signals in specific neuronal subsets mainly located in the cerebral cortex, hippocampus and the amygdala. Transcriptomic analysis revealed specific subsets of Ghsr+/Cnr1+ glutamatergic neurons in the hippocampus and amygdala, as well as different subtypes of Ghsr+/Cnr1+ neurons in the midbrain, hypothalamus, pons, and medulla. Thus, we revealed that GHSR and CB1R interact differentially across specific regions of the mouse brain, providing new insights into how these receptors' actions are integrated. Current findings may open new avenues for dual therapeutic interventions in metabolic disorders, obesity, and psychiatric conditions.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Receptors, GhrelinBrainReceptor, Cannabinoid, CB1NeuronsGhrelinAnimalsMaleMiceMice, TransgenicMice, Inbred C57BL

Stichwörter der Autor:innen

CB1RCo-distributionGHSRGhrelin

Substanzen

Receptors, GhrelinReceptor, Cannabinoid, CB1Ghrelin

Autor:innen und Institutionen

  • Laboratory of Neurophysiology of the Multidisciplinary Institute of Cell Biology [IMBICE, Argentine Research Council (CONICET) and Scientific Research Commission, Province of Buenos Aires (CIC-PBA), National University…
  • Institut des Biomolécules Max Mousseron, Univ Montpellier, CNRS, ENSCM, Montpellier, France.
  • Department of Psychological & Brain Sciences, Indiana University, Bloomington Indiana, USA.
  • Clinical Psychoneuroendocrinology and Neuropsychopharmacology Section, Translational Addiction Medicine Branch, Intramural Research Program and National Institute on Alcohol Abuse and Alcoholism Division of Intramural C…
  • Center for Hypothalamic Research and Division of Endocrinology & Metabolism, Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, TX, USA.
  • Department of Surgical Sciences, Functional Pharmacology and Neuroscience, University of Uppsala, Uppsala, Sweden. mperello@imbice.gov.ar.

Förderung

  • NIDDK NIH HHS
  • Fondo para la Investigación Científica y Tecnológica
  • Ministerio de Ciencia, Tecnología e Innovación
  • NIH HHS
  • National Institutes of Health
  • Uppsala University

Zitieren

APA

Saenz, C., Fernandez, G., Llovera, R., Tolosa, M. J., Cantel, S., Fehrentz, J. A., Mackie, K., Leggio, L., Zigman, J., De Francesco, P. N., & Perello, M. (2024). Growth hormone secretagogue receptor and cannabinoid receptor type 1 intersection in the mouse brain. Brain Structure and Function. https://doi.org/10.1007/s00429-024-02876-3

Vancouver

Saenz C, Fernandez G, Llovera R, Tolosa MJ, Cantel S, Fehrentz JA, et al. Growth hormone secretagogue receptor and cannabinoid receptor type 1 intersection in the mouse brain. Brain Structure and Function. 2024. doi:10.1007/s00429-024-02876-3

BibTeX
@article{Saenz2024,
  author = {Saenz, Camila and Fernandez, Gimena and Llovera, Ramiro and Tolosa, María J and Cantel, Sonia and Fehrentz, Jean-Alain and Mackie, Kenneth and Leggio, Lorenzo and Zigman, Jeffrey and De Francesco, Pablo N and Perello, Mario},
  title = {Growth hormone secretagogue receptor and cannabinoid receptor type 1 intersection in the mouse brain},
  journal = {Brain Structure and Function},
  year = {2024},
  doi = {10.1007/s00429-024-02876-3}
}
Kostenlos starten →